Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-16
2011-08-16
Yu, Melanie J (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007900, C435S007920, C436S501000, C436S811000
Reexamination Certificate
active
07998691
ABSTRACT:
The present invention concerns methods and kits for diagnosing a disease condition characterized by non-physiological levels of hepcidin, comprising obtaining a tissue or fluid sample from a subject; contacting the sample with an antibody or fragment thereof that specifically binds to a polypeptide corresponding to the mid-portion or C terminus of a hepcidin protein, and quantifying the hepcidin level using an assay based on binding of the antibody and the polypeptide; wherein the non-physiological level of hepcidin is indicative of the disease condition. The present invention also concerns diagnostic methods and kits for applications in genetic technological approaches, such as for overexpressing or downregulating hepcidin. The present invention further concerns therapeutic treatment of certain diseases by treatment of subjects with hepcidin and agonists or antagonists of hepcidin.
REFERENCES:
patent: 3724390 (1973-04-01), Beer et al.
patent: RE30026 (1979-06-01), Hanna et al.
patent: 4464465 (1984-08-01), Lostrom
patent: 4690065 (1987-09-01), Belanger et al.
patent: 4981151 (1991-01-01), Larson et al.
patent: 5027714 (1991-07-01), England
patent: 5420016 (1995-05-01), Boguslaski et al.
patent: 5432974 (1995-07-01), Yasutake et al.
patent: 5730061 (1998-03-01), Stufflebeam
patent: 5753230 (1998-05-01), Brooks et al.
patent: 6422153 (2002-07-01), Reitsch, Jr.
patent: 7320894 (2008-01-01), Kulaksiz et al.
patent: 7411048 (2008-08-01), Kulaksiz et al.
patent: 2002/0091247 (2002-07-01), Kaser et al.
patent: 2003/0027999 (2003-02-01), Rosen et al.
patent: 2004/0234527 (2004-11-01), Crisanti
patent: 2005/0037971 (2005-02-01), Nicolas et al.
patent: 2007/0092916 (2007-04-01), Kulaksiz et al.
patent: 2007/0124825 (2007-05-01), Nicolas et al.
patent: 2007/0134746 (2007-06-01), Kulaksiz et al.
patent: 00/73454 (2000-12-01), None
patent: 02/098444 (2002-12-01), None
Swinkels et al, Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches, Clinical Chemistry 52:6 pp. 950-968, 2006.
Office Action issued on Dec. 10, 2007 for U.S. Appl. No. 10/299,486.
Office Action issued on Aug. 24, 2007 for U.S. Appl. No. 10/299,486.
Office Action issued on Mar. 27, 2007 for U.S. Appl. No. 10/299,486.
Office Action issued on Jul. 14, 2006 for U.S. Appl. No. 10/299,486.
Office Action issued on Dec. 30, 2009 for U.S. Appl. No. 10/535,608.
Office Action issued on May 14, 2009 for U.S. Appl. No. 10/535,608.
Office Action issued on Dec. 9, 2008 for U.S. Appl. No. 10/535,608.
Office Action issued on Jan. 25, 2008 for U.S. Appl. No. 10/535,608.
Office Action issued on Oct. 28, 2009 for U.S. Appl. No. 11/657,772.
Office Action issued on May 14, 2010 for U.S. Appl. No. 11/657,772.
Office Action issued on Feb. 3, 2011 for U.S. Appl. No. 11/657,772.
Office Action issued on Apr. 14, 2010 for U.S. Appl. No. 12/629,263.
Office Action issued on Mar. 3, 2011 for U.S. Appl. No. 12/629,263.
Darst et al., “Adsorption of the protein antigen myoglobin afects the binding of conformation-specific monoclonal antibodies,”; Biophysical Journal (1988);: vol. 53, pp. 533-539.
Declaration of Alfred Janetzko, Ph.D., D20—Opposition to EP 1392345, Dec. 23, 2009.
Anderson et al., “Iron Absorption and Metabolism,” Curren tOpinion in Gastroenterology (2009): vol. 25; pp. 129-135.
Park et al., Hepcidin, a Urinary Anticrobial Peptide Synthesized in the Liver, The Journal of biological chemistry (Mar. 2001); vol. 276, pp. 7806-7810.
Office Ation issued on Oct. 28, 2008 for U.S. Appl. No. 11/526,997.
Kemna et al., “Hepcidin from discovery to differential diagnosis,” Haematologica 93(1) 2008, pp. 90-97.
Strongin, Laboratory Diagnosis of Viral Infections, Sensitivity, Specificity, and Predictive Value of Diagnostic Tests: Definitions and Clinical applications, Lennette, ed. Marcel Dekker, Inc. New York, pp. 211-219, 1992.
Nemeth et al., “Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein,” Blood (Apr. 1, 2003): vol. 101, No. 7, pp. 2461-2463.
Wild, The Immunoassay Handbook, Stockton Press, 1994, pp. 66.
Diamandis et al, Immunoassay, Academic Press, Chapter 11, The Avidin-Biotin System (1996), pp. 237-255.
Brugnara, Carlo, “Iron deficiency and erythropoiesis: New Diagnostic Approaches,” Climincal chemistry 2003; vol. 49, No. 10, pp. 1573-1578.
UniProtKB/Swiss-Prot entry Q5U9D2, HEPC CANFA, pp. 1-3, Jun. 28, 2006.
UniProtKB/Swiss-Prot entry P81172, HEPC Human, pp. 1-3, Jun. 28, 2006.
UniProtKB/Swiss-Prot entry Q8MJ80, HEPC Pig, pp. 1-3, Jun. 28, 2006.
UniProtKB/Swiss-Prot entry Q9EQ21, HEPC Mouse, pp. 1-4, Jun. 28, 2006.
Andrews, N. C. (2000) Annu, Rev. Genomics Hum. Genet. 1, 75/98.
Philpott, C.C. (2002) Heatology 35, 993-1001.
Beutler et al., (2001) Drug-Metab. Dispos. 29, 495/499.
Collawn et al., (1990) Cell 63, 1061/1072.
Kawabata et al., (1999) J. Biol. Chem. 274, 20826-20832.
Camasehella et al., (2000) Nat. Genet. 25, 14-15.
Fleming et al., (2002) Proc. Natl. Acad. Sci. USA 99, 10653/10658.
Fleming et al., (2000) Proc. Natl. Acad. Sci. USA 97, 2214/2219.
Subramaniam et al., (2002) Cell biochem Biophys. 36, 235/239.
Krause et al., (2000) FEBS Lett. 480, 147-150.
Nicholas et al., (2002) Proc. Natl. Acad. Sci. USA 99, 4396-4601.
Pigeon et al., (2001) J. Biol. Chem. 276, 7811-7819.
Nicolas et al, (2001) Proc. Natl. Acad. Sci. USA 98, 8780/8785.
Kulaksiz et al., (2002) Proc. Natl. Acad. Sci. USA 99, 6796-6801.
Kulaksiz et al., (2002) Am. J. Pathol. 161, 655-664.
Rost et al., (1999) Hepatology 29, 814-821.
Hunter et al., (2002) J. Biol. Chem., M205305200.
Kawabata et al., (2000) J. Biol. Chem. 275, 16618-16625.
Frazer et al., (2002) Gastroenterology 123, 835-844.
Aden et al., (1979) Nature 282, 615-616.
Schwartz et al., (1985) EMO J. 4, 899-904.
Zhou et al., (1998) Proc. Natl. Acad. Sci. USA 95, 2492-2497.
Levy et al., (1999) Blood 94, 9-11.
Santos et al., (1996) J. Exp. Med. 184, pp. 1975-1985.
Anderson et al., (2002) Biochem. Soc. Trans. 30, 724-726.
Ravel R., Laboratory Iron Studies, Clinical Laboratory Medicine: Clinical Application of Laboratory Data, 6th Ed. Mosby-Year Book, Inc., 1995, pp. 67 and 605.
Weinstein DA et al., Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease, Blood, Nov. 15, 2002, vol. 100, No. 10, pp. 3776-3781; pre-published on Jun. 28, 2002.
Malecki EA et al., Transferrin response in normal and iron-deficient mice heterozygotic for hypotransferrinemia; effects on iron and manganese accumulation, Biometals. Sep. 1998;11(3):265-76.
Craven et al., Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis, Proc Natl Acad Sci U S A., May 1987; 84(10):3457-61.
Hartman KR et al., Microcytic Anemia With Iron Malabsorption: An Inherited Disorder of Iron Metabolism, American Journal of Hematology, Apr. 1996; 51(4):269-75.
Irwin JJ et al., Anemia in children, Am Fam Physician, Oct. 2001; 64:1379-86.
Fargion S et al., Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia, Blood, Nov. 15, 2000; 96(10):3653-5.
Goodnough LT et al., Erythropoietin, iron, and erythropoiesis, Blood, Aug. 1, 2000 ;96(3):823-33.
Brill JR et al., Normocytic Anemia, Am Fam Physician, Nov. 15, 2000;62(10):2255-64.
Diamandis et al., Immunoassay, Academic Press, Chapter 11, The Avidin-Biotin System, pp. 237-255, 1996.
Wild et al., The Immunoassay Handbook, Chapter 2, Components, pp. 49-54, 1994.
Ashurst, P.R., Dennis, M.J., Analytical Methods of Food Authentication, 1998, p. 253, Blackie Academic and Professional, Thomson Science, London, UK.
Garcia-Beato, R., Melero, J.A., The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner, J. General Virology, 2000, pp. 917-927,vol. 81, UK.
Tang, R., et al. Epitope Mapping of Monoclonal Antibody to Integrin aLb2 Hybrid Domain Suggests Different Requirements of affinity States for Interce
Geacintov Cyril E.
Janetzko Alfred
Kulaksiz Hasan
Stremmel Wolfgang
Counts Gary
DRG International, Inc.
Fox Rothschild LLP
Norton Gerard P.
Yu Melanie J
LandOfFree
Diagnostic method for diseases by screening for hepcidin in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic method for diseases by screening for hepcidin in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method for diseases by screening for hepcidin in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2669261